Does Rallies show Form 4 insider transactions for BKYI?

Yes. Rallies tracks BKYI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BKYI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BKYI. It does not provide personalized investment advice.

BKYI (BIO-key International, Inc. Common Stock) Stock Analysis - Insider Trades

BIO-key International, Inc. Common Stock (BKYI) is a publicly traded Industrials sector company. As of May 21, 2026, BKYI trades at $3.46 with a market cap of $5.76M and a P/E ratio of -3.84. BKYI moved -30.51% today. Year to date, BKYI is -41.33%; over the trailing twelve months it is -56.75%. Its 52-week range spans $3.40 to $36.80. Rallies surfaces BKYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BKYI stock inside the company?

Recent BKYI insider activity includes DEPASQUALE MICHAEL W bought 1.62K, DEPASQUALE MICHAEL W bought 1.62K, DEPASQUALE MICHAEL W bought 2.50K, DEPASQUALE MICHAEL W bought 2.50K, and Sullivan James David bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BKYI Key Metrics

Key financial metrics for BKYI
Metric	Value
Price	$3.46
Market Cap	$5.76M
P/E Ratio	-3.84
EPS	$-0.90
Dividend Yield	0.00%
52-Week High	$36.80
52-Week Low	$3.40
Volume	0
Avg Volume	0
Revenue (TTM)	$6.32M
Net Income	$-4.25M
Gross Margin	78.40%

Recent BKYI Insider Trades

DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 1.62K (~$1.36K) on Sep 16, 2025.
DEPASQUALE MICHAEL W bought 2.50K (~$1.88K) on Sep 15, 2025.
DEPASQUALE MICHAEL W bought 2.50K (~$1.88K) on Sep 15, 2025.
Sullivan James David bought 10.00K (~$7.70K) on Aug 22, 2025.

Latest BKYI News

BIO-key Executes 1-for-10 Reverse Split, Nasdaq Suspends Trading; Shares Move to OTC Markets — May 12, 2026
BIO-key Announces 1-for-10 Reverse Split to Regain Compliance, Reduce Shares to 1.1M — Apr 28, 2026
BIO-key Projects 50% H1 Revenue Growth to $5M and Profitability — Apr 16, 2026
BIO-key Books $280K Follow-On Order, Pushes Defense Sales Past $2M — Mar 5, 2026

BKYI Analyst Consensus

BKYI analyst coverage data. Average price target: $0.00.

Common questions about BKYI

Who is trading BKYI stock inside the company?: Recent BKYI insider activity includes DEPASQUALE MICHAEL W bought 1.62K, DEPASQUALE MICHAEL W bought 1.62K, DEPASQUALE MICHAEL W bought 2.50K, DEPASQUALE MICHAEL W bought 2.50K, and Sullivan James David bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BKYI?: Yes. Rallies tracks BKYI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BKYI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BKYI. It does not provide personalized investment advice.